ArticleCardio-oncology (London, England)2026
Coronary artery calcification score as a prognostic factor in patients undergoing allogeneic stem cell transplantation - a retrospective analysis.
Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary artery calcification (CAC) scoring can be measured as a by-product of computed tomography (CT). CAC scoring reflects the general cardiovascular risk profile of patients. The aim of the present study was to determine the prognostic role of CAC on overall survival (OS) in patients with different hematological diseases undergoing allogeneic stem cell transplantation.
methodsA retrospective analysis was conducted on all patients undergoing peripheral blood stem cell transplantation between January 2015 and October 2021. A total of 121 patients (68 male patients, 56.1%) with a mean age of 53.1 ± 13.6 years were identified in the data base and included into the present study. The clinical CT scan to rule out infectious foci was used to assess the CAC score for each patient. The semiquantitative Weston score was measured to quantify CAC.
resultsA total of 67 patients (54.9%) died during the course of the study. A total of 52 patients (42.6%) had visible calcifications on CT images, whereas 70 patients (57.4%) had no calcifications (CAC score 0). There was no association between the CAC score with OS, with an HR of 1.14 (95% CI 0.89; 1.45), p = 0.28) as a metric variable and HR of 1.33 (95% CI 0.82; 2.15) as a dichotomized variable (CAC score 0 versus positive CAC score). There was no association between CAC score and occurrence of sepsis or graft-versus host disease after transplantation.
conclusionsThe presence of CT-defined coronary calcifications has no prognostic relevance in patients undergoing allogeneic stem cell therapy. The impact of CT-defined cardiovascular risk factors appears to be relatively modest in this heterogeneous patient sample.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.